Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced the presentation of preclinical data on the...
Debiopharm, an oncology and infectious disease focused biopharmaceutical company based in Switzerland, today announced data releases on 3 investigational products including Debio 0123 (Selective...
Myeloid Therapeutics, Inc., a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases, presented new late-breaking data at the American Association...
